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A method was developed to detennine the affinities of antimuscarinic drugs at M1 receptors. [3H](±)-Telenzepine served as 
radioligand in crude preparations of calf superior cervical ganglia and showed high affinity for a single receptor population. 
consisting of M1 receptors (K 0 = 1.12 nM). Kinetic experiments showed monophasic association (k1 =0.017 min-I nM- 1) and 
dissociation (k_ 1 = 0.017 min- 1) kinetics, the half-life of dissociation being 41 min at 37°C. The kinetie K0 value amounted to 
1.00 nM. M1 affinities for pirenzepine, methoctramine. hexahydro-sila-difenidol and p-fluoro-hexahydro-sila-difenidol detennined 
in competition experiments were similar to those found in functional studies with MI receptors in rabbit isolated vas deferens. The 
binding assay was used to deterriline the affinities of the (R) and (S) enantiomers of tertiary (trihexyphenidyl, hexahydro-difenidol. 
hexbutinol, p-fluoro-hexbutinol) and quatemary musearlnie antagonists (trihexyphenidyl methiodide. hexbutinol methiodide). 
Comparison of results obtained with the rabbit vas deferens suggested that the ionic environment may influence the affinities. 
[ 3H]( ± )-Telenzepine; Musearlnie M1 receptors; Superior cervical ganglia (ealO; Hexahydro-difenidol analogues; Trihexyphenidyl; 
Hexbutinol; Stereoselectivity 
I. Introduction 
At least three subtypes of musearlnie receptors (M1• 
M 2 and M 3) have been identified on the basis of the 
affinities of antagonists determined in funetional ex-
periments as well as in radioligand binding studies (for 
review, see Levine and Birdsall, 1989). There is a 
eandidate M4 receptor, found in rat striatum (Wael-
broeek et al., 1990) and NG108-15 cells (Michel et al., 
1989), whieh is eonsidered to be the pharmaeologieal 
correlate of the m 4 gene product (Brann et al.. 1988). 
This concept was reeently eonfirmed by studies with 
cloned, sequeneed and expressed complementary ON A 
encoding these receptors (Brann et al., 1988; Levine and 
Birdsall, 1989). 
Musearlnie M1 reeeptors are found in diserete re-
gions of the brain (Hammer et al., 1980; Watson et al., 
1983; 1984), in the intramural enteric nervaus system 
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(North et al., 1985) and in peripheral autonomie ganglia 
(Hammer and Giaehetti, 1982; Giraldo et al.. 1985; 
Newberry and Priestley. 1987; Eltze et al., 1988). 
Binding studies with mammalian sympathetic ganglia 
have revealed the presence of multiple receptors for 
muscarinic ligands (Hammer and Giaehetti, 1982; Wat-
son et al., 1984; Giraldo et al., 1985; Galvan et al .• 
1989), whieh has been confirmed in funetional studies 
(Newberry and Priestley, 1987). 
In many investigations pirenzepine (Hammer et al .• 
1980) andjor [3H]pirenzepine (Watson et al., 1983) 
have been used as selective antagonists to Iabel M1 
receptors seleetively. However, in most of the binding 
studies in peripheral tissues, the binding of pirenzepine 
has been measured indireetly in competition experi-
ments, sinee the ratio receptor bindingj non-specific 
binding is too Iow to aehieve direct specifie [ 3 H] 
pirenzepine binding. More reeently, telenzepine has been 
reported to possess a more than 10-fold higher affinity 
for musearlnie reeeptor subtypes than pirenzepine, 
whilst its reeeptor selectivity for M1 muscerinie recep-
tors is the same (Eltze, 1988; Schudt et al., 1988; 1989; 
Eveleigh et al., 1989; Galvan et al., 1989). In eontrast to 
tlb 
pirenn!pine. there are two chemieally stable enanti-
\llllets of telenzepine. the stereoselectivity ratio at Mt 
re-.--eptors being ca. 400-500 (Eveleigh et al., 1989~ Schudt 
et al.. 1989). 
The aim of the present study was to design a simple 
modd to determine the affinities of drugs acting at 
musearlnie M1 receptors. We therefore investigated the 
binding behaviour of musearlnie M1 receptors present 
in ealf superior cervieal ganglia by using [3H]( ± )-telen-
zepine as a selective radioligand and compared its bind-
ing with that of [ 3H]pirenzepine. Furthermore. the 
kinetic behaviour of [ 3H]( ± )-telenzepine binding was 
studied in ealf ganglia. sinee it has been reported to 
dissociate slowly from muscarinic M 1 receptors 
( Eveleigh et al .• 1989; Galvan et al.. 1989). 
Besides these direct binding experiments. whieh were 
intended to elucidate the MI receptor binding character· 
istics of [ 3H]( ± )-telenzepine in calf superior cervical 
ganglia. we perfonned competition experimenls with 
antimuscarinic drugs. The compounds investigated were 
pirenzepine (Hammer et al.. 1980). methoctramine 
(Melchiorre et al., 1987~ Waelbroeck et al.. l989a), 
racemic hexahydro-sila-difenidol (Mutschler and Lam-
brecht. 1984; Lambrecht et al.. 1989a) and racemic 
p-fluoro-hexabydro-sila-difenidol (Lambrecht et al.. 
1988a: 1989a) as reference drugs. In addition. the M1 
affinities of the enantiomers of trihexyphenidyl (!), 
trihexyphenidyl methiodide (~). hexabydro-difenidoJ Q ), 
hexbutinol (~). hexbutinol methiodide (2) and p-fluoro-
hexbutinol (~) (fig. 1) (Lambrecht et al., 1988b; Feifel et 
al .• 1990) were determined. The pK 1 values of these 
compounds were compared with previously published 
pA:! values obtained in functional experiments with 
presynaptic MI musearlnie heteroreceptors in isolated 
rabbit vas deferens (Lambrecht et al., 1988a,b~ Feifel et 
al.. 1990; Eltze and Figala. 1988; Eltze, 1988), since 
these neuronal musearlnie receptors in rabbit vas de-
ferens have been shown tobe of the ganglionic Mt type 
(Eitze et al.. 1988). Additionally, stereoselectivity ratios 
for the affinities of the chiral compounds were calcu-
lated because of their relevance in musearlnie receptor 
subtype identification (Lambrecht et al., 1988b; 1989b; 
Feifel et al., 1990; Waelbroeck et al., 1989b ). 
Some of the present results have been reported 
elsewhere (Feifel et al., 1989: Lambrecht et al., 1989a). 
2. Materials and methods 
2.1. Membrane preparation 
The preparation of crude pellets of calf superior 
cervical ganglia and the binding experiments were per-
formed in Tris-HCI buffer of the following composition 
(mM): Tris (tris(hydroxymethyl)aminomethane) 50.0, 
NaCl 120.0, MgCJ 2 5.0, adjusted with HCI to pH 7.4 at 
,...-· 
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Fig. 1. Chemical structure of trihexyphenidyl (!), trihexyphenidyl 
methiodide (~). hexahydr<'-difenidol Q), hexbutinol (~. hexbutinol 
methiodide ~) and p-ßuoro-hexbutinol (§). The asterisk denotes the 
centre of chirality. 
4 ° C and at 37 ° C for tissue preparation and binding 
experiments. respectively. 
Calf superior cervical ganglia were obtained from a 
regional slaughterhouse and brought to the Iabaratory 
within 70 min. After separation of surrounding tissue, 
crude ganglia were minced with scissors and homoge-
nized in ice-cold buffer solution (30 g tissue wet 
weight/100 ml) by means of an Ultra-Turrax (TP 18/2, 
Janke + Kunkel KG, Staufen i.Br., FRG) at maximal 
speed for 2 X 30 s. The resuJting suspension was centri-
fuged (Mikro Rapid/K 1305, Hettich, Tuttlingen, FRG) 
at 160 X g for 10 min and the supernatant was sep-
arated. The pellet was ground a secend time and 
processed as before. The supernatants were combined 
and centrifuged (B-60 Z ultracentrifuge, IEC, Needham 
Heights, MA, USA) at 100000 X g for 60 min. The 
supernatants were removed and the resulting pellets 
were stored at - 20 ° C until required. The pellets con-
sisted of 20% of the wet weight of the original tissue. No 
differen~es in binding parameters were observed after 2 
months storage of preparations (data not shown). 
Protein concentration was determined according to 
the BioRad method (Bradford, 1976), using bovinc 
serum albumin as standard. A factor for the conversion 
of the wet weight of the pellets to g protein was esti-
mated ( = 0.062): however, receptor densities are ex-
pres~ed with reference to the wet weight of the pellets. 
2.2. Ligandbinding assays 
Frozen pellets wer.e resuspended in ice-cold buffer 
solution with a Potter ·Elvehjem (type 853202, Braun. 
Melsungen, FRG; 10 strokes at 1000 rpm). Allbinding 
experiments were performed in 6-ml glass vials in a 
final volume of 0.35 ml per sample, usually with a tissue 
density of ca. 5 mg pellet wet weightjml. Different 
tissue concentrations were used in some experiments to 
determine the M1 affinity of [ 3HK ± )-telenzepine and to 
investigate its binding to M1 receptors as a function of 
protein concentration. The incubations for the Satura-
tion and competition experiments were carried out in a 
shaking water bath (37°C, 120 rpm) for 120 min. 
Specific binding was obtained by subtracting the radio-
activity bound in the presence of to-s M atropine 
(non-specific binding) from the radioactivity bound in 
the absence of atropine (total binding). All experiments 
were carried out in duplicate and were repeated at least 
twice. Each sample contained 0.05 ml solution of 3H-
Iabelled ligand (for concentrations see below), 0.05 ml 
of buffer or a solution of atropine (saturation and 
kinetic experiments) or competitor (competition experi-
ments) and 0.25 ml tissue suspension. 
Incubations were tenninated by the addition of 2 ml 
of ice-cold buffer followed by rapid vacuum filtration 
through Whatman GF /C glass fibre filters (Tamson, 
Zoetermeer, NL), which were washed twice with 2 ml 
and twice with 3 ml of 0.9% (w/v) aqueous NaCI 
solution. The filters were placed into 6-ml polyethylene 
scintillation vials (Milli-68 , Lumac, Landgraaf, NL), 4 
ml of Aqualuma® was added and after 5-10 h ß-decay 
was counted in a Packard Tri-Carb 460 CD liquid 
scintillation counter at an efficiency of 45%. 
Similar experiments carried out in the presence and 
absence of the protease inhibitor phenylmethylsulfonyl 
fluoride (PMSF) revealed no differences in binding 
paramet'rs (data not shown). Therefore no prolease 
inhibitors were used in this study. 
2.3. Saturationexperiments 
For saturation curves nine different concentrations 
of the 3H-labe11ed ligands were used, 0.05-8 nM 
[ 3 H]( ± )-telenzepine and 0.13-20 nM [ 3H]pirenzepine, 
respectivel y. 
2.4. Kinetic experiments 
fjxed concentrations ( = [00 ]) of 1.1 and 2.2 nM 
[ 3H]( ± )-telenzepine were incubated and association was 
determined by terminating the reaction after different 
time intervals (2-150 min). Dissociation of [3H]( ±)-tel-
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enzepine was measured after a 60-min incubation and 
consecutive addition of 10- 3 M atropine to the sam-
ples; the reaction was stopped after 2-95 min. Five 
independent experiments were performed. 
2.5. Competition experiments 
In competition experiments, a fixed concentration of 
0.8 nM [3H]( ± )-telenzepine and 11 increasing con-
centrations of competitor (0.05-50 times the estimated 
K 1 value) were added to separate samples. In some 
cases, when Hili coefficients proved to be significantly 
greater than unity, 0.5-1.0% bovine serumalbuminwas 
added to the incubation vials (see below). 
2.6. Data analysis 
Binding parameters (K 0 , K 1 and RT (total receptor 
density) values) were calculated by fitting model func-
tions for one and for two binding sites using the 
FARMFIT program on an IBMcomputer (VM 370) of 
the Universiteit Rekencentrum Nijmegen, NL. FARM-
FIT uses essentially the same iterative non-linear Ieast-
squares regression procedure as the well-known LIG-
AND program, originally written by Munson and 
Rodbard (1980) and described by McPherson (1985). 
The statistical difference between one-site and two-site 
receptor models was determined by comparing the re-
sidual variaru:e between the predicted and actual data 
points in an F-test (P < 0.05). 
The kinetic data were analysed using the KINETIC 
subroutine of the computer program LIGAND. Dis-
sociation . ..;onstants (k _1) and observed association con-
stants (kobst) were fitted by appropriate functions and a 
kinetic K 0 value was calculated according to the follow-
ing equation: K 0 = k_ 1jk1, where k1 represents the 
actual association constant according to k1 x [00 ] + 
k_ 1 = kobsl with [00 ] representing the concentration of 
[ 3H)( ± )-telenzepine. A t112 value for dissociation was 
calculated by using the equation t112 = 0.693jk_ 1. 
2. 7. Statistics 
The data are presented as means ± S.E.M. Linear 
regression analyses were done with the Ieast-squares 
method. Student's t-test (P < 0.05) was used to de-
termine the statistical significance of the differences 
between mean values. 
2.8. Drugs and chemieals 
Racemic [3 H]telenzepine (specific activity 85 
Cijmmol, Iot 2425-235) was a generous gift from Byk 
Gulden Lomberg, Konstanz, FRG. [3H]Pirenzepine 
(specific activity 74.4 Cijmmol, Iot 2604-012) was 
purchased from NEN Du Pont, 's-Hertogenbosch, NL. 
pj~nzepi~ dihydnlChloride ( Boehringer lngelheim. 
FRG) and n'k!thoctramine tetrahydrochloride (Dr. C. 
Mekhiorre. lk"llogna. ltaly) were kindly donated. 
Ra"-enuc hexahydro-sila-difenidol hydrochloride 
(Tacke !t al .• 1985}. (R)- and (S)-trihexyphenidyl hydro-
chloride ((R)-! · HCI and (S)-! · HCI) (Schjelderup 
et al .• 1987). (R)- and (S)-trihexyphenidyl methiodide 
((R)- ~ and (S)- ~) (Schjclderup et al.. 1987). (R)- and 
(S}-hexahydro--difenidol hydrochloride ((R)- J · HCI 
and (S)- J · HCI) (Tacke et al.. 1989). (R)- and (S)-
hexbutinol ((R) - ~ and (S) - 4> (Tacke et al.. 1989) and 
(R)- and (S)-hexbutinol methiodide ((R)- 2 and (S)- ~) 
(Feifel et al.. 1990) were synthesized in our laboratories 
according to the methods described in the literature. 
Racemic p-Ouoro-hexahydro-sila-difenidol hydrochlo-
ride was prepared in a similar way as hexahydro-sila-
difenidol (unpublished results). The enantiomers of p-
Ouonrhexbutinol ((R)- ~ and (S)- §) were synthe-
sized in a similar way as (R)- and (S)-hexbutinol ((R) - ~ 
and (S)- 4> (unpublished results). The enantiomeric 
excess (ee) of the enantiomers of !-§ was > 99.8%. 
determined by calorimetric analysis as described by 
Tacke et al. ( 1 989). 
Aqualuma was purchased from Lumac. Landgraaf, 
NL. All other chemieals were obtained from commer-
cial· sources and were used as purchased. 
3. ResuiiS 
3.1. Saturation studies 
[ 3H]Pirenzepine exhibited an unfavourable specific 
to non-specific binding ratio in crude pellets of calf 
superior cervical ganglia (CSCG)~ the non-specific bind-
ing amounting to 50-70% of the total bound radioactiv-
ity in the concentration range of 2-20 nM. The binding 
parameters determined in this preparation (K 0 = 6 ± 4 
nM. RT = 11 ± 3 pmolfg wet weight. n = 3) could not 
be regarded as a reliable basis for competition experi-
ments and therefore no further sturlies were undertaken 
with this radioligand. 
Specific binding of [3H]( ± )-telenzepine to M1 recep-
tors in CSCG was saturable and of high affinity. Non-
specific binding accounted for 16% (maximal value) of 
total binding (fig. 2). Scatchard plot analysis (Scatchard, 
1949) (fig. 2. inset) indicated the presence of a homoge-
neaus population of binding sites. A dissociation con-
stant (K 0 ) of 1.12 ± 0.02 nM and a receptor density 
(RT) of 22.6 ± 0.3 pmoljg pellet wet weight. equal to 
1.40 pmoljg protein, were obtained (6.2 ± 0.1% of the 
wet weight of the pellet represents membrane protein). 
Incubations with various tissue concentrations (5, 12, 17 
and 21 mg pellet wet weightjml. respectively) did not 
show significant changes in dissociation constant (K 0 ) 
and receptor density (RT ). Specific binding at a con-
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Fig. 2. Representative binding curves of [3 H]( ± )-telenzepine (Tz) at 
musearlnie M1 recepcors in crudc pellets of calf superior cervical 
ganglia. Specific binding was the difference between total and non-
specific binding. The inset shows a Scatchard plot or the saturation 
isotherm. 
centration of 1.1 nM [ 3H]( ± )-teJenzepine increased lin-
early with these tissue concentrations (data not shown). 
The specifically bound radioactivity amounted to 12.1 
± 0.6 pmoljg pellet wet weight. 
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Fig. 3. Rate of association <•> and dissociation <•> (alter addition of 
10- 5 M atropine) of specific ( 3 HJ( ± )-telenzepine binding at 
muscarinic M1 receptors in crude pellets of calf superior cervical 
gangtia (given as percentage of maximal binding) as a function of 
time. The data represent the means of five separate experiments. 
S.E.M. values were smaller than S% in all cases and are thcrefore not 
shown. 
3.2. Kinetic studies 
The kinetics of the binding of [ 3 H]( ± )-telenzepine to 
M1 receptors in calf superior cervical ganglia could be 
best described by assuming monoexponential functions 
for association (kobst- (5.1 ± 0.5) X 10- 2 min- 1; k1 = 
(1.7 ± 0.2) X 10-2 min-• nM- 1) and dissociation (k_ 1 
= (1.7 ± 0.1) X 10-2 min- 1; t112 = 41 ± 3 min) (fig. 3). 
Non-specific binding amounted to less than 10% of the 
total binding at equilibrium and was constant over the 
time range examined (data not shown). The kinetic K 0 
value (1.00 ± 0.02 nM), calculated as k_ 1fk 1, was very 
similar tothat found in saturation experiments (1.12 ± 
0.02 nM), thus confirming that there was a simple 
bimolecular interaction. 
3.3. Competition binding studies 
Preliminary competition studies with bexahydro-
sila-difenidol, p-fluoro-hexahydro-sila-difenidol and 
compounds ~-~ (fig. 1) showed that the binding data 
were best fitted by a one-binding site model with Hili 
coefficients (nH) significantly gre~.ter than unity (data 
not shown). However, if 0.5-1% bovine serum albumin 
was added to the incubation medium, Hill coefficients 
not significantly different from unity were obtained. 
The displacement curve of (R)-trihexyphenidyl methio-
dide ((R) - ~) bad a Hili coefficient smaller than 1 and 
was adequately described by a two-binding site model. 
Fractlonal sp..::lflc Inhibition 
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However, the fraction of low-affinity binding sites was 
very small, and the estimated K 0 for the higb-affmity 
binding sites determined in the two-site model did not 
differ significantly from that found in the one-site anal-
ysis (data not shown). All other compounds investigated 
showed no significant deviation from a concentration-
dependent competitive interaction with telenzepine at a 
single binding site. Some representative competition 
curves are shown in fig. 4; the mean pK 1 values of all 
compounds are listed in table 1. 
In general, the (R) enantiomers of compounds !-J 
exhibited higher affinity than their corresponding (S) 
antipodes, whereas the (R) and (S) enantiomers of com-
pounds with a triple bond (H) showed onJy slight 
differences in their binding affinities. The (R) enanti-
omers of trihexyphenidyl ((R) - !) and trihexyphenidyl 
methiodide ((R) - ~) were very potent antimuscarinic 
compounds at M1 receptors in CSCG with pK 1 values 
of 9.01 and 9.47, respectively. (R)-hexahydro-difenidol 
((R) -J), pirenzepine, hexahydro-sila-difenidol, as well 
as both enantiomers of hexbutinol (~ and hexbutinol 
methiodide ~). showed high and intermediate affinity 
(pK 1 values 8.20-7.35), respectively. p-Fluoro-
hexahydro-sila-difenidol, methoctramine, (S) - !. (S) -
~ and both enantiomers of p-fluoro-hexbutinol (§} ex-
hibited relatively low affinity (pK 1 values 7.08-6.36), 
whereas the (S) enantiomer of hexahydro-difenidol {(S) 
- J) was a very poor antimuscarinic agent with a pK 1 
value of 5.91. 
2 3 4 5 6 
- log [antagonist] (nM) 
Fig. 4. Displacement of specific binding of [3HJ( ± )-telenzepine from muscarinic M1 receptors ~n c~de pellets of calf superior ccrvical ganglia by 
pirenzepine (e). methoctramine ( + ), hexahydro-sila·difenidol (A) and p-fluoro-hexahydro-sila-dtferudol (0). The data represent the means of three 
to ~ight independent experiments. S.E.M. values were smaller than 5% in all cases and are therefore not shown. 
Mflnit~ \·alu~ tpK 1 an\1 pA~) of musearlnie antagonists and stereo-
~ü\it~ tR);'tS) ratios fl\f chir.ll compounds oh1:1ined in binding 
~tudi~ wlth (~Hit± )-tdenzeplne labdled M1 n.>ceptors in calf super-
t\'1" ~~f'·ic.sl gangh:t (l"'SCG. pK1) as well !ls in functional e"perimeuts 
with M1 f\."'."eptors in r.1bbit isolated \'as deferens ( R VD. pA 2 ). The 
affinity ,·alueo. represent the means± S.E.M. For binding experiments. 
the numbeno (n) of independent experiments are given in parentheses. 
tR)/(S) r.!tk-s represent the antilogs of the difrerences between corre-
~mding pK 1 or pA;: 'lialues.. n:spectively. pA 2 values were taken from 
.. Eltze (1988). tt Ehze and Figa1a (1988),-= tarnbrecht et al. (1988a). 
.t lambn.-cht et al. (1988b) and c: Feifel et al. (1990). 
G.lrnpound pK 1 (CSCG) (n) pA2 (RVO) (R)/(S) ratio 
CSC'G RVD 
Pin:RZq)ine 7.S5 ±0.02 (8) 7.79±0.10 a 
Methoctra-
mine 6.S9 ± 0.02 (3) 6.85±0.07 t> 
He:uhydro-
sila-difenidol 7.62 ±0.03 (3) 7.92±0.07 a 
p-Fluoro-
he.,ahydro-
sila-difenidol 6.92 ± l\03 (3) 6.68±0.03.: 
Trihe."typhenidyl (!) 
<R>-! q.oi ±0.04 {3) 
(S)-! b.35±0.06 (4) 
10.11 ± 0.01 d 
457 1700 6.88±0.09d 
Tribe."<yphenidyl methiodide (~) 
(R)-~ 9.47±0.13 (3) 
(S)- ~ 7.08 ±0.01 (3) 
10.61 ±0.10 .t 245 661 7.79±0.04 d 
Hexah)'dro-difenidol {J) 
tR>-J 7.97±0.04(3) 
(S)-} 5.91±0.02(J) 
8.71 ±0.05 ~ 
115 550 5.97±0.04~ 
Hexbutinol (~) 
(R)-~ 7.75±0.09(4) 
(S)-~ 7.35 ±0.09 (4) 
8.78±0.05 c 
2.5 107 6.75±0.07c 
HC)(butinol methiodidc: ~) 
(R)-~ 8.20±0.02 (3) 
(S)- ~ 7.54 ± 0.10 (4) 
9.43 :t 0.06 ~ 
4.6 40 7.83±0.05 ~ 
p-Fiuoro-he"butinol (§) 
CR)-~ 6.85±0.04(8) 
(S)-~ 6.59±0.18 (5) 
8.08±0.06 ~ 
1.8 34 6.55±0.ose 
3.4. Comparison of affinities for M1 receptors in calf 
ganglia and rabbit vas Jeferens 
Binding afrinities (pK 1 values) for M 1 receptors in 
calf superior cervical ganglia were found to be highly 
correlated with functional potencies (pA 2 values) at M1 
receptors in rabbit isolated vas deferens (r 2 = 0.86) (fig. 
~). However, the slope of the experimental equality line 
was not equal to unity (slope = 0.66 ± 0.07). 
Pirenzepine. methoctramine, hexahydro-sila-difen-
idoJ and p-nuoro-hexahydro-sila-difenidol revealed pK 1 
values in calf superior cervical ganglia quite similar to 
the pA2 values in rabbit vas deferens (table 1 and fig. 5) 
and rat ganglia (Eitze et al.. 1988: Lambrecht et al.. 
1989a; Field and Newberry. 1989). thus confirming the 
selective labelling of M1 receptors in calf ganglia with 
r'H]( ± )~telenzepine. The same holds true for the affini-
ties of the (S) enantiomers of compounds J. ~ and ~ 
determined in calf ganglia and rabbit vas deferens. The 
(S) enantiomers of compounds !. ~ and ~. as weil as the 
(R) enantiomers of all compounds ((R) -!-(R)- ~). 
showed binding affinities in calf ganglia (pK 1 values) 
different from the pA 2 values observed in rabbit vas 
deferens. most of them being lo\\ter by factors of 3.4-17 
(table 1. fig. 5). However. (S)-hexbutinol ((S)- ~). ex-
hibited a pK 1 value (7.35) that exceeded the respective 
pA 2 value in rabbit vas deferens by a factor of 4. 
3.5. Stereose/ectivity ratios 
The stereoselectivity ratios at M 1 receptors in calf 
superior cervical ganglia were lower than those obtained 
in rabbit vas deferens. For compounds without a triple 
bond in the carbon chain (! -J, fig. 1 ), stereoselectivity 
was lower by factors of 2.7-4.8. For tbe acetylenic 
enantiomers <4-~). there was no pronounced stereoselec-
tivity at M1 receptors in ca1f ganglia. 
pK1 valuas {CSCG·M1) 
5 6 7 8 9 10 11 
pA2 values (RVD-M1) 
Fig. S. Relationship between rnean pA 2 and pK 1 values. respectively. 
(see table 1) of pirenzc:pine (Pz), methoctramine (Met), hexahydro-
sila-difenidol (HHSiD). p-fluoro-hexahydro-sila-difenidol (p-F-
HHSiD) and the (R) and (S) enantiomers of compounds !~ measured 
in functional studies using rabbit vas dererens and at M1 binding sites 
in calf superior cervical ganglia. The dotted line represents the 1 : 1 
relationship. All data were best correlated by the solid line, with a 
slope different from unity (slope = 0.66 ±0.07, r 2 • 0.86). 
4. Discussion 
4.1. {JH}( ± )·Telenzepine as j'adio/igand in crude pre-
parations of calf superior cervical ganglia 
The present study was designed to develop a simple 
method to determine the affinity of antimuscarinic 
agents for M1 reeeptors in ealf superior cervical ganglia, 
using the highly potent novel radioligand ( 3H]( ±)-tel-
enzepine. In contrast, [ 3H]pirenzepine did not Iabel 
musearlnie M1 reeeptors in crude ganglia preparations 
satisfactorily due to unfavourable specificjnon-specific 
binding ratios. The non-specific binding of [3HK ± )· 
telenzepine was low enough in ganglionic preparations 
to determine reproducibly M1 affinities in saturation as 
weil as in competition experiments. The presence of 
about 30-50% oi M2 receptors in superior cervieal 
ganglia (Giraldo et al., 1985; Galvan et al., 1989) did 
not seem to influenee the selective labelling of M1 
reeeptors, since Scatchard representation of the data 
(fig. 2, inset) indicated a homogeneaus receptor popula-
tior.. 
The racemic structure of telenzepine and the ex-
istence of chemically stable enantiomers raised ques-
tions about the affinities of these enantiomers at 
musearinic M1 reeeptors in calf superior cervical ganglia. 
As shown by Eveleigh et al. (1989), the affinity of ( + )-
and (- )-telenzepine towards M1 receptors present in 
rat eerebral cortex dirfer by a factor of 510, with ( + )-
telenzepine being more potent than the respective (-) 
enantiomer. Therefore, it is reasonable to assume that, 
in calf superior cervical ganglia, only ( + )-telenzepine 
will be bound to M1 receptors when the raeemate is 
used. The availability of the pure ( +) enantiomer of 
[ 3H]telenzepine would aid further progress in musearlnie 
receptor research. 
The results of the kinetic experiments in calf ganglia 
with [3H](±)-telenzepine (k 1 = 0.017 min-• nM-1, k_ 1 
= 0.017 min- 1, K 0 = 1.00 nM) confirmed both the 
affinity value estimated from saturation experiments 
(K 0 = 1.12 nM) and the monoexponential character of 
the ligand-receptor interaction. The slow dissociation of 
( 3H]( ± )-telenzepine from M1 receptors, with a half-time 
of about 41 min, is consistent with Observations re-
ported previously (Schudt et al., 1988; Eveleigh et al., 
1989; Galvan et al., 1989). 
lt should be noted that in order to achieve reason-
able receptor density in the membrane preparation, the 
procedure for preparing the crude pellets of calf ganglia 
is critical. l:ligh tissue concentrations are required for 
effective homogenization with an Ultra Turrax, al-
though a great loss of tissue (ca. 80%) has tobe accepted, 
which is due to enrichment of th~ membrane fraction. 
4.2. Binding affinities of antimuscarinic drugs 
In general, the binding affinities of the anti-
musearlnie compounds investigated were consistent with 
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a competitive interaction between these drugs and the 
[ 3 H]( ± )-telenzepine-labelled muscarinic M1 receptor 
population. The observed deviations (Hili slopes greater 
than unity for some compounds in preliminary experi-
ments and the significantly better two-binding site fit 
for the quaternary compound (R)- f) might be ex-
plained by the different structural and physico-chemical 
properlies of the compounds. 
Compounds with a triple bond (~~). as weil as those 
with a central silanol moiety (hexahydro-sila-difenidol 
and its p-fluoro analogue). seemed to adhere to the glass 
vials or other materials during the incubations. As a 
consequence. at low concentrations the actual con-
centration of competitor in the incubation mixture was 
lower than the value calculated. thus resulting in an 
apparently higher amount of radioligand bound. At 
high concentrations of competitor. however, adsorption 
was saturated and caused relauvely little additional 
binding of radioligand and therefore the slope of the 
fitted competition curve was greater than unity. Ad-
sorption was circumvented by using bovine serum al-
bumin in the experiments with these compounds. The 
Hi11 slopes were shifted to values not significantly dif-
ferent from unity and no effect on the affinity constants 
of the compounds was observed. 
Previous investigations of the behaviour of anti-
musearlnie compounds in direct binding and competi-
tion experiments have revealed heterogeneity of 
antagonist binding sites, which has been explained by 
isomerization of the antagonist-receptor complex (Jarv 
et al.. 1979). For instance, Lee and El-Fakahany (1985) 
reported on such effects with ( 3 H]quinuclidinyl ben-
zilate as radioligand in competition experiments with 
quaternary antimuscarinic compounds at musearlnie re-
ceptors in rat brain. Since classical quatemary anti-
muscarinic compounds fail to discriminate between 
muscarinic receptor subtypes (El-Fakahany et al., 1986). 
this effeet should not be regarded as being caused by 
the presence of two distinct receptors. In contrast to 
EI-Fakahany et al. (1986), who found different equi-
librium dissociation constants when they analysed N-
methylscopolamine binding in various [ 3 H]quinuclidinyl 
benzilate-labelled brain tissues by a one-site or a two-site 
model, analysis of (R)-trihexyphenidyl methiodide ((R) 
- f) binding did not reveal significantly different dis-
sociation constants in the one-site model and the high-
affinity site of the two-site model in ( 3H]( ± )-telen-
zepine-labelled M1 receptors in calf ganglia, possibly 
due to the small fraction of low-affinity sites. 
4.3. Affinities in calf superior cervical ganglia and rabbit 
vas deferens 
Comparison of the affinities for M1 receptors in calf 
superior cervical ganglia and the antimuscarinic poten-
cies in rabbit vas deferens revealed some differences in 
tbe ~1h~'lutc \'alues of the compounds investigated ( ta-
hle 1. fi~. 5). Olle reason for these discrepandes could 
be the diffen!llt ionic conditions in the bindtng and 
functional experiments. Tris-HCl buffer. which is simi-
lar to the buffers used in previous binding studies with 
ganglionic tissues (Hammer and Giaehetti. 1982). was 
used in the binding assays for M1 receptors in ealf 
ganglia: however. modified Krebs buffer (for eomposi-
tion see Feifel et al.. 1990) was used as the bath fluid in 
functional ex.periments with M1 receptors of rabbit vas 
deferens. Although both buffers are similar to the physi-
ological environmen! in terms of their ionic strength. 
distinct influences on receptor-ligand interaction eannot 
be exduded due to their different ionie eomposition. 
As has been shown recently by Delmendo et al. 
( 1989). the influenee of different ionic eondition. on the 
binding affinities of antimuscarinic agents may com-
plicate attempts to eorrelate binding and funetional 
da:a. Therefore. any correlation between affinities de-
termined under different ionie eonditions should be 
examined more in tenns of their rank order of poteney 
than in terms of their absolute values. 
In conclusion. the new radioligand [ 3H]( ± )-telen-
zepine is useful for musearlnie reeeptor research. It 
shows high affinity for musearlnie M1 receptors and 
Iabels them selectively even in tissues with unfavourable 
specificjnon-specific binding ratio for [3 H]pirenzepine. 
Crude preparations of ealf superior cervical ganglia 
Iabelied \\ith rHJtelenzepine ean be used as a simple 
model to investigate the M1 properlies of anti-
musearlnie drugs. 
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